Product Information

BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.2233 per EA under NDC 70954041410. Its NADAC has been published 229 times since Jun 29, 2022.

FDA first approved this application on Nov 4, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Bisoprolol Fumarate and Hydrochlorothiazide market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB

Bisoprolol Fumarate and Hydrochlorothiazide
$0.2233per EA
Low Outlier

Strength

10; 6.25 mg/1; mg/1

NDC

70954041410

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215562

FDA Approved

11/4/2021

TE Code

AB

On Market Since

11/4/2021

Pharmacological Classes

Adrenergic beta-Antagonists
Increased Diuresis
Thiazide Diuretic
Thiazides
beta-Adrenergic Blocker

Price Statistics

The NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB has been published 229 times since Jun 29, 2022, and over the history we have for it it has declined 33.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2233 per EA
All-time high$0.3489 (Nov 16, 2022)
All-time low$0.1227 (Nov 20, 2024)
52-week high$0.2242
52-week low$0.2006
Median price$0.2251
Average price$0.2418
Largest weekly change+49.9% (Dec 18, 2024)
Weeks tracked229
Tracking sinceJun 29, 2022

Price History

1W

0.0%

1M

+6.7%

3M

+11.3%

6M

+3.0%

1Y

+8.3%

3Y

-9.9%

5Y

N/A

All

-33.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB, manufactured by ANI Pharmaceuticals, Inc., is $0.2233 per EA (NDC 70954041410), effective Nov 11, 2026.

How has the price of BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB changed over time?

Over the history we have for it, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB has declined 33.6%. It has been tracked across 229 weekly CMS publications since Jun 29, 2022.

What are the highest and lowest recorded NADAC prices for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?

Since Jun 29, 2022, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB has ranged from a low of $0.1227 (Nov 20, 2024) to a high of $0.3489 (Nov 16, 2022), with a median of $0.2251 per EA.

Are there cheaper alternatives to BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB, is $0.2207 per EA — about 1% below BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB.

Who manufactures BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?

BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB (NDC 70954041410) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.